- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01797263
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial (POYSE)
February 10, 2020 updated by: VA Office of Research and Development
The Pain Outcomes comparing Yoga versus Structured Exercise (POYSE) Trial is a 2-arm parallel group, randomized clinical trial to compare the effectiveness of a yoga-based intervention (YOGA) with that of a structured exercise program (SEP) for subjects with fibromyalgia.
The study aims are: 1) to compare the interventions' (YOGA vs. SEP) effects on overall fibromyalgia severity at 1 month (early response), 3 months (immediate post-intervention) and at 6 and 9 months (sustained effects); 2) to compare the interventions effects on specific fibromyalgia symptoms (pain, sleep, and fatigue), functional impairment, and related outcomes (quality of life, psychological symptoms); and 3) to compare the cost-effectiveness of the interventions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study sample will include 306 Veterans with fibromyalgia.
Patients will be randomized to one of two treatment arms.
The YOGA arm will involve a standardized 12-week, yoga-based intervention.
The yoga intervention will consist of three treatment components: 1) in-person group yoga taught by a certified yoga therapist; 2) a relaxation audio recording for home-use; and 3) a DVD recording to reinforce concepts taught during in-person yoga sessions.
Patients randomized to the structured exercise program (SEP) arm will participate in a 12-week exercise program delivered in a group/class format and supervised by a fitness instructor.
In addition, SEP patients will receive a DVD (for home use) describing the benefits of aerobic exercise for fibromyalgia, a one-on-one consultation session with the fitness instructor, an individualized exercise prescription, and supervised exercise sessions for 12 weeks.
Study Type
Interventional
Enrollment (Actual)
256
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202-2884
- Richard L. Roudebush VA Medical Center, Indianapolis, IN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Veterans will be eligible if they have:
- Widespread Pain Index (WPI) greater than 7 and Symptom Severity Scale (SS) greater than 5 or WPI 3-6 and SS greater than 9.
- Symptoms have been present at a similar level for at least 3 months
- The subject does not have a disorder that would otherwise explain the pain
- Moderate pain severity (pain severity score greater than 5)
- No changes in fibromyalgia medications for last 4 weeks
- Access to a working telephone
Exclusion Criteria:
Exclusion criteria includes:
- Severe medical conditions in which exercise is contraindicated (such as significant cardiovascular disease, COPD or asthma needing home oxygen, stroke or TIA in last 6 months, cancer (other than skin cancer) and receiving treatment for it
- Active psychosis
- Hospitalized for psychiatric reasons within the last 6 months
- Active suicidal ideation
- Moderate to severe cognitive impairment
- Involvement in ongoing yoga classes or moderately intense exercise program in the last 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Yoga
A 12-week yoga intervention modified for Veterans with fibromyalgia.
Each weekly session will last approximately 75 minutes.
The standardized sequence of yoga poses will be introduced to participants and the instructor will tailor them to the participant's needs and abilities.
Deep breathing exercises will be taught and emphasized throughout every session.
Participants will be encouraged to exercise according to their limits, rather than rigid adherence to posture techniques.
The yoga intervention will be tailored to the individual.
It will include low intensity, low impact modified poses adapted with pathophysiologic changes of fibromyalgia in mind.
Participants will also be given a Playaway(c) device with guided relaxation exercise recorded on it and asked to listen to it three times a week to reinforce the in person yoga session content.
|
A 12-week yoga intervention modified for Veterans with fibromyalgia.
Each weekly session will last approximately 75 minutes.
The standardized sequence of yoga poses will be introduced to participants and the instructor will tailor them to the participant's needs and abilities.
Deep breathing exercises will be taught and emphasized throughout every session.
Participants will be encouraged to exercise according to their limits, rather than rigid adherence to posture techniques.
The yoga intervention will be tailored to the individual.
It will include low intensity, low impact modified poses adapted with pathophysiologic changes of fibromyalgia in mind.
Participants will also be given a Playaway(c) device with guided relaxation exercise recorded on it and asked to listen to it three times a week to reinforce the in person yoga session content.
|
|
Active Comparator: Structured Exercise
A 12-week group exercise session consisting of a graded aerobic exercise program.
The program will start at low intensity with gradual increases in exercise intensity and duration.
Each weekly session will last 75 minutes.
The fitness instructor will teach participants to use a table-top ergometer at a sub-maximal level, determine baseline fitness, and develop an individualized exercise prescription.
The fitness instructor will provide educational tips on exercise and selection of physical activities.
Participants will be given a pedometer and heart rate monitor to track their exercise at home.
They will also be given an exercise DVD to use at home.
|
A 12-week group exercise session consisting of a graded aerobic exercise program.
The program will start at low intensity with gradual increases in exercise intensity and duration.
Each weekly session will last 75 minutes.
The fitness instructor will teach participants to use a table-top ergometer at a sub-maximal level, determine baseline fitness, and develop an individualized exercise prescription.
The fitness instructor will provide educational tips on exercise and selection of physical activities.
Participants will be given a pedometer and heart rate monitor to track their exercise at home.
They will also be given an exercise DVD to use at home.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fibromyalgia Impact Questionnaire Revised (FIQR) Total Score
Time Frame: 3 month
|
This measure will be assessed at Baseline, 1, 3, 6 and 9 months.
The 3 month is the primary end point and the 6 and 9 month assessments are for sustained effect.
Min:0, Max: 90.
Higher Score = Worse Outcome.
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fibromyalgia Impact Questionnaire-Revised Difficulty Subscale
Time Frame: 3 Month
|
This represents a subscale of the FIQr and measures patient perceived difficulty related to fibromyalgia.
Min:0, Max: 20.
Higher Score = Worse Outcome.
|
3 Month
|
|
Fibromyalgia Impact Questionnaire-Revised Impact Subscale
Time Frame: 3 Month
|
This is a subscale of the FIQr and measures the overall impact of fibromyalgia symptoms.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Fibromyalgia Impact Questionnaire Revised Symptoms Subscale
Time Frame: 3 Month
|
This subscale of the FIQr provides an overall fibromyalgia symptom score.
Min:0, Max: 100.
Higher Score = Worse Outcome
|
3 Month
|
|
Brief Pain Inventory (BPI) Severity Subscale
Time Frame: 3 month
|
is an 11-item, multidimensional pain measurement tool with demonstrated reliability in patients with arthritis as well as other pain conditions.
The BPI rates the intensity of pain as well as the interference of pain with mood, physical activity, work, social activity, relations with others, sleep, and enjoyment of life.Min:0, Max: 40.
Higher Score = Worse Outcome.
|
3 month
|
|
PHQ-9 for Depression
Time Frame: 3 Month
|
will be used to assess depression severity.
Several studies have validated the PHQ-9 as a diagnostic measure with excellent psychometric properties.
Internal consistency has consistently been shown to be high (Cronbach's alpha > 0.80) and test-retest assessment showed the PHQ-9 to be a responsive and reliable measure of depression treatment outcomes.
Min:0, Max: 27.
Higher Score = Worse Outcome.
|
3 Month
|
|
GAD-7 Anxiety Scale
Time Frame: 3 Month
|
This 7-item scale represent a measure of anxiety symptom severity and provides a score from 0 to 21 with higher scores representing more severe anxiety
|
3 Month
|
|
PTSD Checklist of Symptoms
Time Frame: 3 Month
|
This 17-item scale assess PTSD symptom severity and provides a severity score; with higher scores representing more severe PTSD.
Min: 0, Max: 85 with higher scores representing more severity.
|
3 Month
|
|
SF-12 Physical Score (Health-related Quality of Life)
Time Frame: 3 Month
|
The SF-12 is a well-validate measure of health-related quality of life; providing a physical and mental health component summary score.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
SF-12 Mental Score (Health-related Quality of Life)
Time Frame: 3 Month
|
The SF-12 is a well-validate measure of health-related quality of life; providing a physical and mental health component summary score.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Multi-dimensional Fatigue Inventory
Time Frame: 3 Month
|
This scale assesses overall fatigue and has been well-validated and used in other fibromyalgia trials.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
MOS Sleep Scale - Problems Index
Time Frame: 3 Month
|
This scale assesses different aspects of sleep quality and provides an overall index with higher scores representing more severe sleep problems.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Pain Catastrophizing Scale
Time Frame: 3 Month
|
This 13-item scale assesses pain catastrophizing which has been found to be a predictor of poor treatment response.
Min: 0. Max: 52.
Higher Score = Worse Outcome.
|
3 Month
|
|
Arthritis Self-efficacy Scale
Time Frame: 3 Month
|
This scale has been well-validated to assess self-efficacy or confidence in a person's ability to complete a task.
Min: 0, Max: 60.
Higher score represents improvement.
|
3 Month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2013
Primary Completion (Actual)
July 2, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
February 20, 2013
First Submitted That Met QC Criteria
February 20, 2013
First Posted (Estimate)
February 22, 2013
Study Record Updates
Last Update Posted (Actual)
February 24, 2020
Last Update Submitted That Met QC Criteria
February 10, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D1100-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on Yoga
-
Universität Duisburg-EssenCompleted
-
Ataturk UniversityKTO Karatay UniversityRecruiting
-
University of Texas at AustinCompleted
-
Adiyaman University Research HospitalCompletedDepression | Stress | Anxiety | Psychological ResilienceTurkey
-
NMP Medical Research InstituteYog-Kulam; Department of Zoology, University of Rajasthan, IndiaCompleted
-
NMP Medical Research InstituteWarwick Research Services; Yog-KulamCompleted
-
Northwestern UniversityCompleted
-
University of MinnesotaCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Pain | Breast Cancer | FatigueUnited States
-
Saglik Bilimleri UniversitesiThe Scientific and Technological Research Council of TurkeyCompletedStress | Anxiety | Telerehabilitation | Yoga | University StudentsTurkey